http___bg.gsk.com_bg-bg__D0_BD_D0_B0_D1_83_D1_87_D0_BD_D0_B8-_D0_B8_D0_B7_D1_81_D0_BB_D0_B5_D0_B4_D0_B2_D0_B0_D0_BD_D0_B8_D1_8F__1.xml
1.1 2.1 3.1 4.1 5.1 6.1
Научни изследвания Науката може да подобри здравето и благосъстоянието по толкова много начини - от разработването на здравни продукти за ежедневния комфорт до животоспасяващи лекарства и ваксини. Като ГлаксоСмитКлайн и чрез фирмите, които сме наследили, имаме 150-годишно наследство от прилагане на науката за откриване и разработване на нови лекарства, ваксини и продукти без рецепта, които помагат да се промени живота на много хора. За да продължим нашия успех в намирането на нови продукти, ние имаме повече от 13 000 души, които работят в нашата организация за научноизследователска и развойна дейност, посветена на намирането на нови начини за подобряване на лечението на болести и състояния. Научете повече за основните области в науката, върху които сме се фокусирали, за това как провеждаме нашите научни изследвания, какво ръководи нашите научноизследователски и развойни дейности и как извършваме клинични изпитвания. Повече информация за научните изследвания на ГлаксоСмитКлайн може да намерите тук: http://www.gsk.com/en-gb/research/
1.1 2.1 3.1 4.1 5.1 6.1 6.2 7.1 8.1 9.1 10.1 11.1 12.1 12.2 13.1 13.2 14.1 14.2 15.1 16.1 17.1 17.2 18.1 19.1 19.2 19.3 19.4 19.5
Research Science can improve health and wellbeing in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines. As GSK and through our heritage companies, we have a 150-year legacy of applying science to discover and develop new medicines, vaccines and consumer healthcare products that help to transform lives. To carry on our success in finding new products, we have more than 13,000 people working across our R&D organization dedicated to finding new ways to improve the treatment of diseases and illnesses. A Canadian R&D Leader GSK has invested more than $1.9 billion since 2001 in Canadian pharmaceutical and vaccines R&D, ranking it among the top 10 contributors to R&D in Canada over the past 15 years across all industries. In 2015 alone, the company invested more than $80 million, ranking GSK among the top 35 contributors across all industries. Clinical Studies - In 2012, GSK invested $40 million in conducting 58 clinical trials across Canada, and involving over 3,500 patients. - In 2012, GSK supported more than 40 Investigator Sponsored Studies with physicians across Canada. - In 2012, GSK sponsored approximately 23 local trials (health economics and outcomes research, phase IV) to support the scientific understanding of our medicines and vaccines in Canada. Supporting R&D Innovation in Canada To accelerate the discovery of new medicines and vaccines, we make collaboration part of our business model. Partnering with academic researchers and public organisations is a key part of our research efforts and we have a range of projects in place to allow us to work with and support new projects that fall within the specific areas of science we are interested in exploring. In Canada, GSK is actively engaged in the support of research and innovation in the life sciences, and the commercialization of new technologies. GSK works actively with academic researchers, university industry liaison and technology transfer offices, and innovation hubs such as MaRS Innovation, the Centre for Drug Research and Development (CDRD), and the Quebec Consortium for Drug Development (CQDM), to identify exciting new opportunities in drug discovery and development for potential collaboration with GSK. Click here to see our current areas of interest. For more information, please contact Amyn Sayani, (905) 819 3185 or Amyn.P.Sayani@gsk.com. Find out about the main areas of science we are focusing on, how we conduct our research, what drives our R&D operations, and view our product pipeline. Sharing our research As part of our commitment to transparency, we are reporting the results of all our research, where the outcomes are perceived to be positive or negative. You can read more about this commitment here. You are leaving our website Although GlaxoSmithKline Inc. offers, as a convenience, links to a number of websites that we believe may offer useful information to our visitors (“Linked Sites”), GlaxoSmithKline Inc. makes no warranty of any kind regarding the accuracy and use of the information on these Linked Sites and is not liable for damages of any kind arising out of your access to, or use of, these Linked Sites. The privacy policies, legal information and procedures described on the GlaxoSmithKline Inc. website do not apply to Linked Sites. You must contact these Linked Sites directly for information on their data collection and distribution policies. Your use of and browsing in Linked Sites are at your own risk. Cancel Continue